Solta CEO and leadership

Scott Hirsch is a Chief Executive Officer at SOLTA MEDICAL INC and is based in New York City, New York. He has worked as Lead Equity Research Analyst, Specialty Pharmaceuticals and Global Generics at Credit Suisse Group AG and Vice President, Portfolio Manager at Plural Investments,LLC. Scott A. works or has worked as Portfolio Manager at Citadel. He studied at The Wharton School between 2004 and 2006 and Rhode Island School of Design.

Jack Glenn joined Thermage in January 2008 as Chief Financial Officer, bringing with him almost 25 years of financial leadership experience with both private and publicly traded companies. He joins the Company from Cholestech, Inc., a publicly traded company providing diagnostic tools for the monitoring and assessment of heart disease, where he held the role of Chief Financial Officer and Vice President of Finance for three years before assisting in its strategic acquisition by Inverness Medical Innovations. Prior to Cholestech, Mr. Glenn held the role of Chief Financial Officer and Vice President of Finance for Invivo Corporation for 14 years. Invivo Corporation, a publicly traded medical device manufacturer, was sold to Intermagnetics in January of 2004 . During Mr. Glenn's tenure at Invivo Corporation, he played a key role in the identification, negotiation and structuring of four successful acquisitions, two secondary public equity offerings and two divestitures of non-strategic businesses. Mr. Glenn holds a BS in business administration from the University of Nevada and an MBA from Santa Clara University.